ClinVar Miner

Submissions for variant NM_001384140.1(PCDH15):c.4103A>G (p.Glu1368Gly)

gnomAD frequency: 0.00016  dbSNP: rs111033449
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039738 SCV000063427 likely benign not specified 2012-04-10 criteria provided, single submitter clinical testing Glu1368Gly in exon 30 of PCDH15: This variant has been identified in 0.01% (1/70 20) of European American chromosomes in a broad population by the NHLBI Exome se quencing project (http://evs.gs.washington.edu/EVS/; dbSNP rs111033449). It is n ot expected to have clinical significance because it did not segregate with hear ing loss in one family tested by our lab and the amino acid residue is not conse rved across mammalian species.
Labcorp Genetics (formerly Invitae), Labcorp RCV000963253 SCV001110397 likely benign not provided 2024-07-01 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001104868 SCV001261763 uncertain significance Usher syndrome type 1 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Ambry Genetics RCV002513556 SCV003682287 uncertain significance Inborn genetic diseases 2022-05-27 criteria provided, single submitter clinical testing The c.4103A>G (p.E1368G) alteration is located in exon 30 (coding exon 29) of the PCDH15 gene. This alteration results from a A to G substitution at nucleotide position 4103, causing the glutamic acid (E) at amino acid position 1368 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
GeneDx RCV000963253 SCV003803304 uncertain significance not provided 2023-11-15 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25203624)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.